Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Green tea cream shows promise for rare 'Fish Scale' skin disease

NCT ID NCT01222000

Symptom relief Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a cream made from green tea extract (Veregen) on 6 people with lamellar ichthyosis, a rare genetic condition that causes severe dry, scaly skin. Participants applied the cream to one side of their body and a standard moisturizer to the other for 4 weeks. The goal was to see if the green tea cream could improve skin scaling and roughness better than moisturizer alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
green tea extract (epigallocatechin-3-gallate) cream
What this could lead to
If it works, this could point toward a new topical treatment to ease skin scaling and roughness in lamellar ichthyosis.
What could go wrong
This is a very small pilot study with only 6 participants, so results may not apply to everyone. The treatment is tested on just one side of the body, and it may not work or may cause skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

6 people

The number who actually took part.

Started

Oct 2010

Finished

Mar 2013

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients of both sexes of at least 8 years and less than 65 years. * Patients with a clinical diagnosis of LI * Patients having at once a score of roughness and a desquamation of intensity moderated in severe (at least 2) on every side of the body, * Patients and\\or relatives / representatives of the parental authority in measure to understandand to follow the procedures of the study * Consent of patient and\\or parents / representatives of the parental authority * Patient member to the Social Security Exclusion Criteria: * Patient of less than 8 years * Pregnant, breast-feeding women or old enough to procreate without reliable medical contraception, * Women with a positive pregnancy test, * Transaminases \> twice the normal. * Patients with congenital ichthyosis others than LI, * Patients with a erythrodermic composent, * Patients affected by LI of the light gravity (score \< 2 for the desquamation or the roughness) on at least a side of the body, * Patients with secondary infection , * Patients with known allergy of to one of the ingredients contained in the tested product, * Patients with specific topical treatment (for example analogues of vitamin A, vitamin D similar), * Patients with topical keratolytic treatment (for example the urea, the hydroxy-acids) in 7 days before the beginning of the clinical trial * Patients and\\or relatives / representatives of the parental authority unable to understand and\\or to follow the procedures of the study, * Tea intake during the trail

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lamellar ichthyosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

autosomal recessive congenital ichthyosis 1 lamellar ichthyosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lamellar ichthyosis

Contacts and locations

Locations

  • Service de dermatologie CHU de Nice

    Nice, France

  • Toulouse University Hospital, Dermatology Department

    Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.